These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34222811)

  • 21. [Antibiotic resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a meta-analysis].
    Aykan SB; Ciftci IH
    Mikrobiyol Bul; 2013 Oct; 47(4):603-18. PubMed ID: 24237429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
    Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single β-lactams versus combinations as empiric therapy for infections with
    Almarzoky Abuhussain SS; Sutherland CA; Nicolau DP
    Infect Dis (Lond); 2020 Jan; 52(1):33-38. PubMed ID: 31595829
    [No Abstract]   [Full Text] [Related]  

  • 28. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
    Jones RN; Stilwell MG; Rhomberg PR; Sader HS
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):331-4. PubMed ID: 19822273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Combination Antibiogram Evaluation for
    Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
    Metan G; Zarakolu P; Hasçelik G; Akova M
    Mikrobiyol Bul; 2006; 40(1-2):23-8. PubMed ID: 16775953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
    Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
    Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Glob Antimicrob Resist; 2018 Jun; 13():60-64. PubMed ID: 29154953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM; Elkhizzi NA
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of Pseudomonas aeruginosa Biofilm Formation and Quorum Sensing Genes in Piperacillin/Tazobactam and Ciprofloxacin Sub-minimal Inhibitory Concentrations].
    Erdal B; Yalınay M; Elmas Ç; Yazıcı GN
    Mikrobiyol Bul; 2020 Oct; 54(4):547-558. PubMed ID: 33107284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms.
    Strateva T; Ouzounova-Raykova V; Markova B; Todorova A; Marteva-Proevska Y; Mitov I
    J Med Microbiol; 2007 Jul; 56(Pt 7):956-963. PubMed ID: 17577062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.